Smart & Biggar announces Lynn Ing as new counselJanuary 3, 2020
Smart & Biggar, Canada’s leading firm for intellectual property law, congratulates Lynn Ing on her promotion to counsel.
Lynn has more than a decade of experience in patent prosecution and litigation, bolstered by her strong scientific expertise and background in cancer research. Among her many accomplishments, Lynn held an integral role in the successful appeal to the Supreme Court of Canada in AstraZeneca v Apotex, 2017 SCC 36, leading to the abolishment of the “promise doctrine” of patent utility in Canada. Lynn advises clients on biotechnology, chemical and pharmaceutical patent applications including for biologics, and represents them in patent infringement, impeachment and damages actions and litigation under the Patented Medicines (Notice of Compliance) Regulations.
To learn more about Lynn, please visit Smart & Biggar’s website.
Smart & Biggar is widely recognized as Canada’s leading firm for intellectual property law. With offices across Canada, and over 100 lawyers, patent agents and trademark agents, we are the largest firm focused purely on IP and related specialty areas. For over 100 years, we have remained devoted to protecting our clients' intellectual property and technology assets. Whether we are advising an innovative company on patent strategy or infringement issues, providing counsel on brand protection and enforcement, or handling the IP aspects of a corporate transaction, we provide clients with solutions to protect, enforce and leverage their IP.
Smart & Biggar
University of Toronto
Year Of Call
Area Of Practice